Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Assembly Bio nets $117.5mm via FOPO

Executive Summary

Assembly Biosciences Inc. (developing therapies for hepatitis B and diseases associated with the microbiome) netted $117.5mm through a follow-on public offering 5.15mm common shares priced at $16.50 and pre-funded warrants to buy 2.42mm shares at $16.499.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies